Navigation Links
Roche Diagnostics Breaks Ground on New Learning and Development Center
Date:11/14/2012

INDIANAPOLIS, Nov. 14, 2012 /PRNewswire/ -- Mayor Greg Ballard today joined Roche Diagnostics President and CEO Jack Phillips as well as other Roche executives and community leaders to break ground on the company's new Learning and Development Center. The center is the first element of a $300 million site transformation investment that was announced in June 2012. The city of Indianapolis and the Indiana Economic Development Corporation offered Roche tax abatements, tax credits and training grants to support Roche's investment.

"Roche's decision to grow and invest in Indianapolis is a testament to our strength as a life sciences center," said Mayor Ballard, who participated in the ceremony held on the company's campus near the intersection of 96th Street and Interstate 69. "They've been an important part of our life sciences heritage for nearly 50 years now, and this expansion signals an important commitment to the region."

"Central Indiana has been our home since 1964 and we are here to stay," said Jack Phillips, president and CEO of Roche Diagnostics, adding that the company's history and growth in the region is due in part to the community's outstanding workforce and partnerships with the state and city that have enhanced job creation. 

The company, a leader in pharmaceuticals and diagnostics, will invest $300 million during the next 10 years at its North American headquarters on the northeast side of Indianapolis.  The capital investments will support the company's growing diagnostics and diabetes care businesses.  The new Learning and Development Center will host the training of more than 1,500 customers from across the nation each year. 

"It is fitting that the new Learning and Development Center is the first phase of our site transformation because it reflects our commitment to always put the customer first," said Phillips.

The ceremony also marked the first public unveiling of the new building's renderings, which when completed will be one of the most unique structures in Central Indiana. The center will employ a distinct architectural style consistent with the company's European heritage.

"As a key piece of our North American Headquarters, the new Learning and Development Center will serve as a hub and gateway for worldwide operations," said Phillips. "We felt that it was important for the building to reflect our global influence, right here in Indianapolis."

About Roche
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2011, Roche had over 80,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 42.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com or www.roche-diagnostics.us.

All trademarks used or mentioned in this release are protected by law.

For further information, please contact:
Todd Siesky
Director, Corporate Communications
Roche Diagnostics Corporation
Indianapolis, IN
(317) 521-3966
todd.siesky@roche.com 


'/>"/>
SOURCE Roche Diagnostics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Rochester Medical Reports Record Fourth Quarter and Fiscal Year Results
2. Mayor Greg Ballard to Join Roche Diagnostics Leaders at Groundbreaking of New Learning and Development Center
3. Rochester Medical Corporation Announces Decision To Exit The Foley Catheter Business
4. Rochester Medical Announces Fourth Quarter 2012 Earnings Conference Call Tuesday, November 13, 2012
5. Roche cytomegalovirus viral load test now available in US
6. Roche Selects Thomson Reuters to Transform the Management of Its Intellectual Property Assets
7. Roche receives FDA clearance for herpes simplex virus type 1 and 2 tests
8. Rochester Medical Reports Third Quarter Results
9. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
10. Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012
11. FDA clears Accu-Chek Combo system - Roches new interactive insulin pump system for people with diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 19, 2017 Cardiology devices segment is anticipated to ... The Cardiology Devices segment is likely to create absolute ... in 2018 over 2017. By the end of 2027, Cardiology ... to US$ 700 Mn, expanding at a CAGR of 18.4% ... Asia Pacific reprocessed medical devices market ...
(Date:4/19/2017)... DALLAS , April 19, 2017  Vanderbilt University ... first patients in Nashville , Tennesse ... Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. ... to provide long-term reflux control by restoring normal function ... nearly 65 million people in the United ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-na├»ve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
Breaking Medicine News(10 mins):